TrialCardiovascular and interventional radiology2019

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.

T Susanna Meijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.